Short answer · Medically reviewed summary · Last updated: 2026-05-08
The primary treatment for Insulinoma is surgical resection, which is curative in approximately 90% of cases where the tumor is localized. For patients who are not candidates for surgery or who have metastatic Insulinoma, medical management focuses on controlling hypoglycemia through diet and pharmacological interventions. What is the standard surgical approach for Insulinoma? Surgery is the gold-standard treatment for Insulinoma.
The primary treatment for Insulinoma is surgical resection, which is curative in approximately 90% of cases where the tumor is localized. For patients who are not candidates for surgery or who have metastatic Insulinoma, medical management focuses on controlling hypoglycemia through diet and pharmacological interventions.
Surgery is the gold-standard treatment for Insulinoma. Depending on the tumor's size and location, surgeons may perform an enucleation (shelling out the tumor) or a formal pancreatectomy. Because Insulinoma tumors are often small and difficult to locate, advanced intraoperative ultrasound is frequently used to guide the surgeon. In cases where the tumor is benign and solitary, surgery provides a definitive cure.
When surgery is not feasible or the disease is malignant, medications are required to prevent life-threatening hypoglycemia. Common approaches include:
Managing Insulinoma requires a collaborative approach due to the complexity of neuroendocrine tumors. Your care team should ideally include an endocrinologist, a pancreatic surgeon, an interventional radiologist (for localization studies), and an oncologist if the tumor is malignant. At DiseaseMaps.org, 15 members have shared their experiences, highlighting the importance of seeking care at centers specialized in neuroendocrine tumor management.
Recent research focuses on Peptide Receptor Radionuclide Therapy (PRRT) using agents like Lutetium Lu 177 dotatate, which delivers targeted radiation to tumor cells. Clinical trials are ongoing to assess the efficacy of these therapies in patients with persistent or metastatic Insulinoma.
Medical disclaimer: Treatment plans for Insulinoma must be personalized by your medical team and this information should not replace professional clinical advice.